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Abstract
Background: The TM4SF10 gene encodes a putative four-transmembrane domains protein of
unknown function termed Brain Cell Membrane Protein 1 (BCMP1), and is abundantly expressed
in the brain. This gene is located on the short arm of human chromosome X at p21.1. The
hypothesis that mutations in the TM4SF10 gene are associated with impaired brain function was
investigated by sequencing the gene in individuals with hereditary X-linked mental retardation
(XLMR).
Methods: The coding region (543 bp) of TM4SF10, including intronic junctions, and the long 3'
untranslated region (3 233 bp), that has been conserved during evolution, were sequenced in 16
male XLMR patients from 14 unrelated families with definite, or suggestive, linkage to the TM4SF10
gene locus, and in 5 normal males.
Results: Five sequence changes were identified but none was found to be associated with the
disease. Two of these changes correspond to previously known SNPs, while three other were
novel SNPs in the TM4SF10 gene.
Conclusion: We have investigated the majority of the known MRX families linked to the TM4SF10
gene region. In the absence of mutations detected, our study indicates that alterations of TM4SF10
are not a frequent cause of XLMR.
Background
Brain Cell Membrane Protein 1 (BCMP1) cDNA was for-
tuitously isolated from a thyroid cDNA library [1]. It
encodes a 181aa-long putative four-transmembrane
domain protein which appears related to both Peripheral
Myelin Protein 22 / Epithelial Membrane Proteins and
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Claudins protein families, and exhibits significant similar-
ities to the Caenorhabditis elegans VAB-9 protein, a protein
that has recently been shown to be involved in the control
of cell adhesion and epidermal morphology [2]. The pro-
tein sequence itself has been extremely well conserved
during evolution, as exemplified by the observation that
human and canine sequences are identical and differ from
the mouse sequence at only 2 positions. The correspond-
ing gene has now been renamed TM4SF10 in man and
mouse, and is located on the X chromosome in both spe-
cies, as well as in the other mammalian species investi-
gated to date [1].
Initial Northern blot analysis of TM4SF10/BCMP1 gene
transcripts distribution in adult dog tissues revealed very
high expression in the brain, and lower but clearly detect-
able levels of expression in most of the tissues examined
[1]. Data mining in the SAGEmap database [3] confirmed
this observation in man, as elevated tag counts have been
reported in brain astrocytoma (SAGE H127 library), brain
ependymoma (SAGE ependymoma 353 and 582 librar-
ies) and normal spinal cord (SAGE normal spinal cord
library) as compared to other tissues. Together with its
localization on the X chromosome, the high expression
level detected in the brain and the putative role of the
encoded protein in specific cell contacts raised the possi-
bility that the TM4SF10 gene may be involved in X-linked
mental retardation (XLMR) in man.
Initially, the TM4SF10 gene was assigned to Xp11.4 [1]. As
the integration between human cytogenetic and DNA
sequence-based maps is still evolving, the gene has been
reassigned to band p21.1. It is noteworthy that TM4SF2,
another gene encoding a four-transmembrane domain
protein, is located at the p11.4-p21.1 border on human
chromosome X, in the very close vicinity of TM4SF10, and
constitutes a known XLMR gene [4,5]. Recent compila-
tions of XLMR families [6-8] mention several conditions
mapped to the Xp11.4-p21.1 region. We report the result
of mutation screening of TM4SF10 in a cohort of XLMR
patients whose gene was mapped to this region of the X
chromosome and does not correspond to TM4SF2.
Methods
Blood genomic DNA was collected from 16 patients (14
unrelated) and 5 unrelated healthy volunteers using a
standard procedure [9]. The patients were affected males
from families with definite, or possible, linkage to the
region at Xp11.4-p21.1. Patients belonged to the follow-
ing published MRX(S) families: MRX9 [10], MRX10 [11],
MRX11 [11], MRX12 [11], MRX18 [12], MRX56 [6] and
MRXS10 [13]. Additional patients were from an XLMR
family with epilepsy [14] and 4 other XLMR families (C.S.,
F.K., J.G., unpublished), a MRXS family with macroceph-
aly and large ears (C.S., unpublished), and another MRXS
family (J.G., unpublished). Chromosomal linkage data
and major phenotypic traits are described in table 1. All
samples were studied anonymously and all procedures
met the standards of our institutional ethics committee.
PCR reactions were performed in a final volume of 100 µl
containing 200 ng of genomic DNA, 1 µg of each primer
(see table 2 for primer sequences), 200 µM of each dNTP,
1X PCR buffer (QIAGEN) and 2.5 units of Taq polymerase
(QIAGEN). Additionally, 10% DMSO or 20% Q solution
(QIAGEN) were also included in some reactions (see table
2). After an initial denaturation step (93°C, 45 sec.), 35
cycles were conducted as follows: 93°C, 45 sec.; annealing
temp. (see table 2), 45 sec.; 72°C, 45 sec. (amplicons Ex1–
Ex3) or 1 min. (amplicons 3'UTR F1–F4). A final exten-
sion step (72°C, 3 min.) was done at the end of the reac-
tion. PCR products were purified using the QIAquick PCR
purification kit (QIAGEN) before sequencing. Purified
PCR fragments were roughly quantitated by agarose gel
electrophoresis using SmartLadder molecular weight
marker (EUROGENTEC) as a quantitative reference.
About 50–100 ng of purified PCR fragment was used in a
DNA sequencing reaction using a nested, internal primer.
DNA sequencing was performed using ABI PRISM BigDye
Terminator Cycle Sequencing Ready Reaction kit (Applied
Biosystems) on an Applied Biosystems 3100 automatic
DNA sequencer. The sequences of the primers are given in
table 3.
Results and discussion
Sequencing of TM4SF10 coding region
The human TM4SF10 gene is composed of 3 exons and
produces a 4 kb-long mRNA. The short coding region
(543 bp) is interrupted by 2 introns and the last and the
largest exon also contains a 3 233 bp-long 3'UTR (see Fig-
ure 1). Initially, we sequenced the coding region and
exon-intron junctions of the gene in the DNAs from 16
XLMR patients and from one normal male (amplicons
Ex1–Ex3, Figure 1). No mutations were identified. One
silent polymorphism was observed at position 186 in the
cDNA sequence (clone DKFZp761J17121; GenBank
accession number AL136550), corresponding to the 3rd
base of the codon Arg59, where a C residue was present in
half of the sequences and a G residue in the other half.
Individual single nucleotide polymorphism (SNP) data
are shown in table 4. It is noteworthy that patients P3 and
P4 who belong to the same family exhibit a difference in
their TM4SF10 gene sequence at this level. This observa-
tion argues against a causal role of the gene in this family.
The 186C>G polymorphism in the TM4SF10 gene had
been previously reported [15].BMC Medical Genetics 2004, 5:22 http://www.biomedcentral.com/1471-2350/5/22
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Sequencing of the 3'UTR
The long 3'UTR sequence of the TM4SF10/BCMP1 tran-
script is highly conserved, with an overall score of 72%
when human, dog, mouse and rat sequences are
compared. As the 3'UTR of mRNAs may contain regula-
tory sequences that participate in the control of gene
expression, we decided to screen this part of the gene as
well. The entire region, including the sequences around
the polyadenylation site, was subdivided into four over-
lapping fragments of approximately 1 kb in length (3'UTR
F1–F4, Figure 1) and sequenced from both ends. In frag-
ment 3' UTR F3 the presence of a stretch of 12 consecutive
A residues on the sense strand resulted in difficulties in
proper reading of the sequences located downstream of
this motif. In order to overcome this problem, an addi-
tional sequence primer (rev2) was used to obtain overlaps
between the 3 separate sequences for each individual
fragment. In the cDNA sequence AL136550 the motif is
composed of 13 A residues, which is a likely sequence
artefact.
TM4SF10 sequence was obtained from 16 patients and 5
controls. Four SNPs were identified in the non-coding
part of the gene: 3 of them were located in the 3'UTR of
the mRNA while the fourth one was located downstream
of the polyadenylation site (Figure 1). Only this last one
(C21559611T) had been previously reported in the SNP
database [15], the other three representing novel SNPs in
the TM4SF10 gene. The individual SNP haplotypes deter-
mined here are described in table 4. It is also noteworthy
that during the course of our investigation, the genetic
defect of one of the unpublished XLMR family included in
the study (see top of table 1) has been identified and
mapped to Xq28, within the MECP2 gene [16].
Schematic of the TM4SF10 gene and single nucleotide poly- morphisms identified in the study Figure 1
Schematic of the TM4SF10 gene and single nucle-
otide polymorphisms identified in the study. The 
structure of the gene is outlined with exons represented as 
light-blue boxes and the coding region as dark-blue areas 
within the boxes. The 3' end of the gene is also enlarged 
(bottom). Amplified regions are delineated and locations of 
sequence primers (arrows) used in this study are depicted. 
Identified SNPs are indicated (dotted lines) with reference to 
genomic contig (GenBank accession number NT_011757) 
sequence coordinates and cDNA (clone DKFZp761J17121; 
GenBank accession numberAL136550) sequence coordinates 
(italics) when relevant. Numbers in parentheses indicate the 
occurrences of the nucleotide in the individual sequences. 
The 3 novel SNPs identified in the work appear in red.
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Table 1: Description of the patients included in the study
Patient Family Linkage data Phenotype
P1, P2 XLMR family (F.K., now MRX79) chromosome X X-linked mental retardation
P3, P4 MRXS10 Xp11.21-Xp11.4 Mental retardation, choreoathetosis, abnormal behavior
P5 XLMR family (F.K.) Chromosome X, pericentromeric Non-syndromic mental retardation
P6 MRX9 Xp11.22-Xp11.4 Non-syndromic mental retardation
P7 MRX10 Xp11.3-Xp21.2 Non-syndromic mental retardation
P8 MRX11 Xp11.3-Xp21.2 Non-syndromic mental retardation
P9 MRX12 Xp11.21-Xp21.2 Non-syndromic mental retardation
P10 MRX18 Xp11.3-Xp21.2 Non-syndromic mental retardation
P11 XLMR family with epilepsy Xp11.23-Xp22.22 Non-syndromic mental retardation, epilepsy
P12 MRXS family (J.G.) Xp21.3-Xq21.3 Non-syndromic mental retardation
P13 XLMR family with macrocephaly 
(J.G.)
Xp11.4-Xq13.1 Macrocephaly, moderate to profound mental retardation
P14 XLMR family (C.S.) Xp11.3-Xp21.1 Seizures, ataxia, aggressive and hyperactive behavior, speech 
delay, mild to moderate mental retardation
P15 MRXS (C.S.) Xp22.22-Xq24 Macrocephaly, prominent ears and moderate to severe 
mental retardation
P16 MRX56 Xp11.21-Xp21.1 Non-syndromic mental retardationBMC Medical Genetics 2004, 5:22 http://www.biomedcentral.com/1471-2350/5/22
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Table 2: PCR conditions and primer sequences used to amplify TM4SF10 gene fragments from total genomic DNA
Amplicon Size Primer sequence PCR conditions
Ex1 442 bp fw: AGAGCCCCGAGGGAGCGA, rev: GGGGACAGGCGGTGACTG Tanneal = 55°C, 10% DMSO
Ex2 447 bp fw: AAATCCTAGCAAACCCCTGG, rev: TCTGCATAGGAAAGGAAGATGG Tanneal = 50°C
Ex3 447 bp fw: CCATCTAGAACAAGCCATCTTTAA, rev: TAAATCAACTGAGCAAACTGCTTG Tanneal = 50°C
3'UTR F1 959 bp fw: GGCCTGGGGTGCAACTATAT, rev: TAGGCAAATGTATGTGGAGGGT Tanneal = 55°C, 10% DMSO
3'UTR F2 1101 bp fw: ATTGGTGCCTCAGCCCTATCTA, rev: GCAACCATTCTTAAGACAAGCT Tanneal = 57°C, 20% Q solution
3'UTR F3 1130 bp fw : CAGTATGTTCTGGTTTTGGCCC, rev : TATCTAACAATGGGTTTGTGGC Tanneal = 57°C, 20% Q solution
3'UTR F4 1097 bp fw : CCTTCTCAGCAAAGAGCCCTAC, rev : AAGGATCTTGGGAGATAATTTG Tanneal = 57°C, 20% Q solution
Table 3: Sequences of the primers used for sequencing of TM4SF10 gene fragments
Amplicon Primer sequence
Ex1 fw: CCGAGGGAGCGAGTCCCC
Ex2 fw: CACATCTGTTGAGCCACTGC
Ex3 rev: GATGCTCCACAAGTGTTTTAGA
3'UTR F1 fw : TGCCTGAACCCTAAGAACTATG, rev : GGAGGGTTAGGGAACAACTTAT
3'UTR F2 fw : CTGCATGAGTTGCTTTTGTACC, rev : GCAACCATTCTTAAGACAAGCT
3'UTR F3 fw : TCTGTTAAGAGCAGGACCACAT, rev1: ACTCGAGATGTGATGATATTGG, rev2 : TATCTAACAATGGGTTTGTGGC
3'UTR F4 fw : AACATGAAAATTGTTGCTTCTC, rev : AAGGATCTTGGGAGATAATTTG
Table 4: Description of the individual TM4SF10 gene SNP haplotypes determined in this study
Exon 1: 186 (Arg59), 
[21589434]
3' UTR: 705, 
[21562747]
3' UTR: 2870, 
[21560583]
3' UTR: 2907, 
[21560546]
3' intergenic: 
[21559611]
N1 C C G T C
N2 (n.d.) C C C C
N3 (n.d.) C C T C
N4 (n.d.) T C T T
N5 (n.d.) C C T C
P1 C T C T T
P2 C T C T T
P3 G C C T C
P4 C C C T C
P5 G C C T T
P6 G C C T T
P7 G C C T C
P8 G C C T C
P9 G C C T C
P10 C C C T T
P11 C T C T T
P12 G C C T C
P13 G C C T C
P14 C C C T T
P15 C T C T T
P16 G C C T C
The first row identifies the source of the DNA, either a normal individual (Nx) or a patient (Px; see also table 1 for the detailed description of the 
patients). The individual bases found at each polymorphic position in the DNA sequence (identified by the nucleotide position in the cDNA 
sequence and/or in the genomic contig sequence [in square brackets]; see also figure 1) are given in the following rows. (n.d.): not determined.Publish with BioMed Central    and   every 
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Conclusions
In this study, we have investigated the majority of the
known MRX families linked to the TM4SF10 gene region.
In the absence of mutations detected, our results indicate
that alterations in the transcribed region of TM4SF10 are
not a frequent cause of XLMR. Although the gene
promoter has not been identified and screened yet, it
appears very unlikely that all mutations would be there.
This work also identified three novel SNPs in the
TM4SF10 gene, which adds to our knowledge of SNP
occurrence within this gene.
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